Conclusion: Sunitinib has antitumor activity in pancreatic neuroendocrine tumors;its activity against carcinoid tumors could not be definitively determined in this nonrandomized study.

• 结论：舒尼替尼对胰腺神经内分泌肿瘤患者有抗肿瘤作用，在本次非随机试验中对类癌的作用尚不确定。